These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10780984)
1. Role of kynurenines in the neurotoxic actions of kainic acid. Behan WM; Stone TW Br J Pharmacol; 2000 Apr; 129(8):1764-70. PubMed ID: 10780984 [TBL] [Abstract][Full Text] [Related]
2. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Carpenedo R; Chiarugi A; Russi P; Lombardi G; Carlà V; Pellicciari R; Mattoli L; Moroni F Neuroscience; 1994 Jul; 61(2):237-43. PubMed ID: 7969905 [TBL] [Abstract][Full Text] [Related]
4. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065 [TBL] [Abstract][Full Text] [Related]
5. In vivo neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in murine hippocampal pyramidal neurons. Ogita K; Okuda H; Yamamoto Y; Nishiyama N; Yoneda Y J Neurochem; 2003 Jun; 85(5):1336-46. PubMed ID: 12753091 [TBL] [Abstract][Full Text] [Related]
6. Effects of pilocarpine and kainate-induced seizures on N-methyl-D-aspartate receptor gene expression in the rat hippocampus. Lasón W; Turchan J; Przewłocki R; Machelska H; Labuz D; Przewłocka B Neuroscience; 1997 Jun; 78(4):997-1004. PubMed ID: 9174068 [TBL] [Abstract][Full Text] [Related]
7. In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus. Ogita K; Okuda H; Watanabe M; Nagashima R; Sugiyama C; Yoneda Y Neuropharmacology; 2005 May; 48(6):810-21. PubMed ID: 15829253 [TBL] [Abstract][Full Text] [Related]
8. Role of desensitization and subunit expression for kainate receptor-mediated neurotoxicity in murine neocortical cultures. Jensen JB; Schousboe A; Pickering DS J Neurosci Res; 1999 Jan; 55(2):208-17. PubMed ID: 9972823 [TBL] [Abstract][Full Text] [Related]
9. Nuclear factor kappa B-mediated kainate neurotoxicity in the rat and hamster hippocampus. Won SJ; Ko HW; Kim EY; Park EC; Huh K; Jung NP; Choi I; Oh YK; Shin HC; Gwag BJ Neuroscience; 1999; 94(1):83-91. PubMed ID: 10613499 [TBL] [Abstract][Full Text] [Related]
10. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
11. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons. Fatokun AA; Smith RA; Stone TW Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115 [TBL] [Abstract][Full Text] [Related]
12. MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain. Gao XM; Tamminga CA J Neural Transm Gen Sect; 1995; 101(1-3):105-13. PubMed ID: 8695041 [TBL] [Abstract][Full Text] [Related]
13. Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats. Vorwerk CK; Kreutz MR; Dreyer EB; Sabel BA Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2382-92. PubMed ID: 8933755 [TBL] [Abstract][Full Text] [Related]
14. Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit. Matteucci A; Cammarota R; Paradisi S; Varano M; Balduzzi M; Leo L; Bellenchi GC; De Nuccio C; Carnovale-Scalzo G; Scorcia G; Frank C; Mallozzi C; Di Stasi AM; Visentin S; Malchiodi-Albedi F Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1070-7. PubMed ID: 20861489 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. Chiarugi A; Carpenedo R; Molina MT; Mattoli L; Pellicciari R; Moroni F J Neurochem; 1995 Sep; 65(3):1176-83. PubMed ID: 7643095 [TBL] [Abstract][Full Text] [Related]
16. Quinolinic acid induces neuritogenesis in SH-SY5Y neuroblastoma cells independently of NMDA receptor activation. Hernandez-Martinez JM; Forrest CM; Darlington LG; Smith RA; Stone TW Eur J Neurosci; 2017 Mar; 45(5):700-711. PubMed ID: 27973747 [TBL] [Abstract][Full Text] [Related]
17. Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists. Behan WM; Stone TW Br J Pharmacol; 2002 Mar; 135(6):1435-42. PubMed ID: 11906956 [TBL] [Abstract][Full Text] [Related]
18. Kynurenic acid attenuates NMDA-induced pial arteriolar dilation in newborn pigs. Bari F; Nagy K; Guidetti P; Schwarcz R; Busija DW; Domoki F Brain Res; 2006 Jan; 1069(1):39-46. PubMed ID: 16388784 [TBL] [Abstract][Full Text] [Related]
20. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors. Kleckner NW; Dingledine R Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]